From Evidence to Impact: Closing the Loop in Pharmacovigilance With Real‐World Data
The views expressed in this article are the personal views of the author(s) and may not be understood or quoted as being made on behalf of or reflecting the position of the regulatory agency/agencies or organizations with which the author(s) is/are employed/affiliated. The authors declare no Conflicts of Interest.
Authors
- Daniel R. Morales (ORCID: https://orcid.org/0000-0002-0063-8069)
- Helga Gardarsdóttir (ORCID: https://orcid.org/0000-0001-5623-9684)
Institutions
- European Medicines Agency (NL)
- University of Iceland (IS)
- Utrecht University (NL)
- University Medical Center Utrecht (NL)
- Pharmo Institute (NL)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1002/pds.70244
- Primary Topic
- Academic integrity and plagiarism
- Type
- article
- Field-Weighted Citation Impact
- 0.00